{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:20:30Z","timestamp":1790198430864,"version":"4.1.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06421-0","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T22:46:18Z","timestamp":1759358778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neonatal hyperbilirubinemia: past lessons, current practices, and future directions"],"prefix":"10.1007","volume":"184","author":[{"given":"Ramesh","family":"Vidavalur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"Suppl 1","key":"6421_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/pr.2013.208","volume":"74","author":"VK Bhutani","year":"2013","unstructured":"Bhutani VK, Zipursky A, Blencowe H et al (2013) Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 74(Suppl 1):86\u2013100. https:\/\/doi.org\/10.1038\/pr.2013.208","journal-title":"Pediatr Res"},{"key":"6421_CR2","first-page":"V11190671","volume":"182","author":"ML Donneborg","year":"2020","unstructured":"Donneborg ML, Hansen BM, Petersen JP et al (2020) An update on unconjugated neonatal hyperbilirubinaemia in Denmark. Ugeskr Laeger 182:V11190671","journal-title":"Ugeskr Laeger"},{"key":"6421_CR3","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41390-021-01692-3","volume":"91","author":"I Qattea","year":"2022","unstructured":"Qattea I, Farghaly MAA, Elgendy M et al (2022) Neonatal hyperbilirubinemia and bilirubin neurotoxicity in hospitalized neonates: analysis of the US Database. Pediatr Res 91:1662\u20131668. https:\/\/doi.org\/10.1038\/s41390-021-01692-3","journal-title":"Pediatr Res"},{"key":"6421_CR4","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1080\/14767058.2021.1960970","volume":"35","author":"R Vidavalur","year":"2022","unstructured":"Vidavalur R, Devapatla S (2022) Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study. J Matern Fetal Neonatal Med 35:7701\u20137706. https:\/\/doi.org\/10.1080\/14767058.2021.1960970","journal-title":"J Matern Fetal Neonatal Med"},{"key":"6421_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CLEP.S373289","volume":"15","author":"Y Sun","year":"2023","unstructured":"Sun Y, Petersen JP, Wu C et al (2023) Neonatal phototherapy and clinical characteristics: the Danish National Patient Registry 2000\u20132016. Clin Epidemiol 15:123\u2013136. https:\/\/doi.org\/10.2147\/CLEP.S373289","journal-title":"Clin Epidemiol"},{"key":"6421_CR6","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1542\/peds.111.5.e555","volume":"111","author":"LR Atkinson","year":"2003","unstructured":"Atkinson LR, Escobar GJ, Takayama JI, Newman TB (2003) Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline? Pediatrics 111:e555-561. https:\/\/doi.org\/10.1542\/peds.111.5.e555","journal-title":"Pediatrics"},{"key":"6421_CR7","doi-asserted-by":"publisher","first-page":"e2023063323","DOI":"10.1542\/peds.2023-063323","volume":"153","author":"L Sarathy","year":"2024","unstructured":"Sarathy L, Chou JH, Romano-Clarke G et al (2024) Bilirubin measurement and phototherapy use after the AAP 2022 newborn hyperbilirubinemia guideline. Pediatrics 153:e2023063323. https:\/\/doi.org\/10.1542\/peds.2023-063323","journal-title":"Pediatrics"},{"key":"6421_CR8","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.3390\/jcm12113738","volume":"12","author":"UM Diala","year":"2023","unstructured":"Diala UM, Usman F, Appiah D et al (2023) Global prevalence of severe neonatal jaundice among hospital admissions: a systematic review and meta-analysis. J Clin Med 12:3738. https:\/\/doi.org\/10.3390\/jcm12113738","journal-title":"J Clin Med"},{"key":"6421_CR9","doi-asserted-by":"publisher","first-page":"e190858","DOI":"10.1001\/jamanetworkopen.2019.0858","volume":"2","author":"J Alk\u00e9n","year":"2019","unstructured":"Alk\u00e9n J, H\u00e5kansson S, Ek\u00e9us C et al (2019) Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden. JAMA Netw Open 2:e190858. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.0858","journal-title":"JAMA Netw Open"},{"issue":"Suppl 1","key":"6421_CR10","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/jp.2008.211","volume":"29","author":"L Johnson","year":"2009","unstructured":"Johnson L, Bhutani VK, Karp K et al (2009) Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 29(Suppl 1):S25-45. https:\/\/doi.org\/10.1038\/jp.2008.211","journal-title":"J Perinatol"},{"key":"6421_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1001\/jamapediatrics.2020.1767","volume":"174","author":"F Okolie","year":"2020","unstructured":"Okolie F, South-Paul JE, Watchko JF (2020) Combating the hidden health disparity of kernicterus in black infants: a review. JAMA Pediatr 174:1199\u20131205. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.1767","journal-title":"JAMA Pediatr"},{"key":"6421_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41372-019-0566-8","volume":"40","author":"ML Donneborg","year":"2020","unstructured":"Donneborg ML, Hansen BM, Vandborg PK et al (2020) Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000\u20132015. J Perinatol 40:194\u2013202. https:\/\/doi.org\/10.1038\/s41372-019-0566-8","journal-title":"J Perinatol"},{"key":"6421_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1542\/peds.2014-0987","volume":"134","author":"MW Kuzniewicz","year":"2014","unstructured":"Kuzniewicz MW, Wickremasinghe AC, Wu YW et al (2014) Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics 134:504\u2013509. https:\/\/doi.org\/10.1542\/peds.2014-0987","journal-title":"Pediatrics"},{"key":"6421_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.earlhumdev.2009.09.003","volume":"85","author":"MJ Maisels","year":"2009","unstructured":"Maisels MJ (2009) Neonatal hyperbilirubinemia and kernicterus - not gone but sometimes forgotten. Early Hum Dev 85:727\u2013732. https:\/\/doi.org\/10.1016\/j.earlhumdev.2009.09.003","journal-title":"Early Hum Dev"},{"key":"6421_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03695-2","author":"R Vidavalur","year":"2024","unstructured":"Vidavalur R, Schettler KF, Dani C et al (2024) Trends of extreme hyperbilirubinemia related infant mortality in select European countries (1990\u20132019). Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-024-03695-2","journal-title":"Pediatr Res"},{"key":"6421_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1007\/s12098-024-05227-6","volume":"91","author":"R Vidavalur","year":"2024","unstructured":"Vidavalur R, Bhutani VK (2024) Managing the historic burden of kernicterus mortality in India. Indian J Pediatr 91:1262\u20131267. https:\/\/doi.org\/10.1007\/s12098-024-05227-6","journal-title":"Indian J Pediatr"},{"key":"6421_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41372-024-01903-9","volume":"44","author":"VK Bhutani","year":"2024","unstructured":"Bhutani VK, Vidavalur R, Wong RJ (2024) Correction: advances to diminish global newborn kernicterus mortality. J Perinatol 44:600\u2013601. https:\/\/doi.org\/10.1038\/s41372-024-01903-9","journal-title":"J Perinatol"},{"key":"6421_CR18","unstructured":"GBD (2021) Level 4 cause- hemolytic disease and other neonatal jaundice. https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-hemolytic-disease-and-other-neonatal"},{"key":"6421_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1542\/peds.111.6.1303","volume":"111","author":"TB Newman","year":"2003","unstructured":"Newman TB, Liljestrand P, Escobar GJ (2003) Infants with bilirubin levels of 30 mg\/dL or more in a large managed care organization. Pediatrics 111:1303\u20131311. https:\/\/doi.org\/10.1542\/peds.111.6.1303","journal-title":"Pediatrics"},{"key":"6421_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archpedi.159.2.113","volume":"159","author":"TB Newman","year":"2005","unstructured":"Newman TB, Liljestrand P, Escobar GJ (2005) Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 159:113\u2013119. https:\/\/doi.org\/10.1001\/archpedi.159.2.113","journal-title":"Arch Pediatr Adolesc Med"},{"key":"6421_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpeds.2015.08.048","volume":"168","author":"A McGillivray","year":"2016","unstructured":"McGillivray A, Polverino J, Badawi N, Evans N (2016) Prospective surveillance of extreme neonatal hyperbilirubinemia in Australia. J Pediatr 168:82-87.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2015.08.048","journal-title":"J Pediatr"},{"key":"6421_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004) Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297\u2013316. https:\/\/doi.org\/10.1542\/peds.114.1.297","journal-title":"Pediatrics"},{"key":"6421_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bcmd.2012.10.004","volume":"50","author":"RD Christensen","year":"2013","unstructured":"Christensen RD, Lambert DK, Henry E et al (2013) Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system. Blood Cells Mol Dis 50:105\u2013109. https:\/\/doi.org\/10.1016\/j.bcmd.2012.10.004","journal-title":"Blood Cells Mol Dis"},{"key":"6421_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpeds.2015.12.067","volume":"171","author":"M Sgro","year":"2016","unstructured":"Sgro M, Kandasamy S, Shah V et al (2016) Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian Guidelines. J Pediatr 171:43\u201347. https:\/\/doi.org\/10.1016\/j.jpeds.2015.12.067","journal-title":"J Pediatr"},{"key":"6421_CR25","doi-asserted-by":"publisher","first-page":"e2022058859","DOI":"10.1542\/peds.2022-058859","volume":"150","author":"AR Kemper","year":"2022","unstructured":"Kemper AR, Newman TB, Slaughter JL et al (2022) Clinical practice guideline revision: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 150:e2022058859. https:\/\/doi.org\/10.1542\/peds.2022-058859","journal-title":"Pediatrics"},{"key":"6421_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1542\/hpeds.2024-008205","volume":"15","author":"A Jameel","year":"2025","unstructured":"Jameel A, Richardson T, Slaughter JL (2025) Impact of the 2022 AAP Guidelines on neonatal hyperbilirubinemia admissions: a PHIS Study. Hosp Pediatr 15:537\u2013544. https:\/\/doi.org\/10.1542\/hpeds.2024-008205","journal-title":"Hosp Pediatr"},{"key":"6421_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jcjq.2024.10.013","volume":"51","author":"MR Michienzi","year":"2025","unstructured":"Michienzi MR, Tomasini DK, Fisher CC, Ponnapakkam AP (2025) Implementation of the revised American academy of pediatrics clinical practice guidelines for hyperbilirubinemia decreases necessity for serum bilirubin and phototherapy. Jt Comm J Qual Patient Saf 51:95\u2013100. https:\/\/doi.org\/10.1016\/j.jcjq.2024.10.013","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"6421_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13052-025-02002-x","volume":"51","author":"C Dani","year":"2025","unstructured":"Dani C, Fusco M, Andreini M et al (2025) Implementation of the 2022 AAP guidelines for neonatal hyperbilirubinemia could reduce the need for phototherapy in Italy. Ital J Pediatr 51:162. https:\/\/doi.org\/10.1186\/s13052-025-02002-x","journal-title":"Ital J Pediatr"},{"key":"6421_CR29","doi-asserted-by":"publisher","first-page":"e820","DOI":"10.1097\/pq9.0000000000000820","volume":"10","author":"LP Chen","year":"2025","unstructured":"Chen LP, Goetz EM, Allen AH et al (2025) A partner hospital intervention to decrease readmissions for newborn hyperbilirubinemia. Pediatr Qual Saf 10:e820. https:\/\/doi.org\/10.1097\/pq9.0000000000000820","journal-title":"Pediatr Qual Saf"},{"key":"6421_CR30","doi-asserted-by":"publisher","unstructured":"Owerko D, Ryan K, Bauer SC et al (2025) Improving quality of care for neonatal hyperbilirubinemia admissions after birth hospitalization. Hosp Pediatr e2024007996. https:\/\/doi.org\/10.1542\/hpeds.2024-007996","DOI":"10.1542\/hpeds.2024-007996"},{"key":"6421_CR31","first-page":"601","volume":"123","author":"CG Ebby","year":"2024","unstructured":"Ebby CG, Allen AH, Shadman KA et al (2024) Aligning newborn hyperbilirubinemia care with american academy of pediatrics guidelines at an urban community hospital. WMJ 123:601\u2013605","journal-title":"WMJ"},{"key":"6421_CR32","doi-asserted-by":"publisher","first-page":"e886","DOI":"10.1542\/peds.2012-0253","volume":"130","author":"M Sgro","year":"2012","unstructured":"Sgro M, Campbell DM, Kandasamy S, Shah V (2012) Incidence of chronic bilirubin encephalopathy in Canada, 2007\u20132008. Pediatrics 130:e886-890. https:\/\/doi.org\/10.1542\/peds.2012-0253","journal-title":"Pediatrics"},{"key":"6421_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/jamapediatrics.2014.3036","volume":"169","author":"YW Wu","year":"2015","unstructured":"Wu YW, Kuzniewicz MW, Wickremasinghe AC et al (2015) Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold: a population-based study. JAMA Pediatr 169:239\u2013246. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3036","journal-title":"JAMA Pediatr"},{"key":"6421_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1542\/peds.2007-2915","volume":"123","author":"BL Burke","year":"2009","unstructured":"Burke BL, Robbins JM, Bird TM et al (2009) Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988\u20132005. Pediatrics 123:524\u2013532. https:\/\/doi.org\/10.1542\/peds.2007-2915","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"6421_CR35","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/jp.2008.212","volume":"29","author":"VK Bhutani","year":"2009","unstructured":"Bhutani VK, Johnson L (2009) Kernicterus in the 21st century: frequently asked questions. J Perinatol 29(Suppl 1):S20-24. https:\/\/doi.org\/10.1038\/jp.2008.212","journal-title":"J Perinatol"},{"key":"6421_CR36","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1542\/peds.106.2.e15","volume":"106","author":"TW Hansen","year":"2000","unstructured":"Hansen TW (2000) Pioneers in the scientific study of neonatal jaundice and kernicterus. Pediatrics 106:E15. https:\/\/doi.org\/10.1542\/peds.106.2.e15","journal-title":"Pediatrics"},{"key":"6421_CR37","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/080352502760311674","volume":"91","author":"TWR Hansen","year":"2002","unstructured":"Hansen TWR (2002) Neonatal jaundice and scientific fraud in 1804. Acta Paediatr 91:1135\u20131138. https:\/\/doi.org\/10.1080\/080352502760311674","journal-title":"Acta Paediatr"},{"key":"6421_CR38","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1651-2227.2010.01898.x","volume":"99","author":"TWR Hansen","year":"2010","unstructured":"Hansen TWR (2010) Twists and turns in phototherapy for neonatal jaundice. Acta Paediatr 99:1117\u20131118. https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01898.x","journal-title":"Acta Paediatr"},{"key":"6421_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41372-019-0439-1","volume":"40","author":"TWR Hansen","year":"2020","unstructured":"Hansen TWR, Maisels MJ, Ebbesen F et al (2020) Sixty years of phototherapy for neonatal jaundice - from serendipitous observation to standardized treatment and rescue for millions. J Perinatol 40:180\u2013193. https:\/\/doi.org\/10.1038\/s41372-019-0439-1","journal-title":"J Perinatol"},{"key":"6421_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/apa.12068","volume":"102","author":"TWR Hansen","year":"2013","unstructured":"Hansen TWR (2013) Curing neonatal jaundice with \u201clanguage of friendship and rays of hope\u201d in the 18th century. Acta Paediatr 102:119\u2013122. https:\/\/doi.org\/10.1111\/apa.12068","journal-title":"Acta Paediatr"},{"key":"6421_CR41","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1038\/s41390-022-02351-x","volume":"93","author":"S Gazzin","year":"2023","unstructured":"Gazzin S, Jayanti S, Tiribelli C (2023) Models of bilirubin neurological damage: lessons learned and new challenges. Pediatr Res 93:1838\u20131845. https:\/\/doi.org\/10.1038\/s41390-022-02351-x","journal-title":"Pediatr Res"},{"key":"6421_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.siny.2014.12.008","volume":"20","author":"VK Bhutani","year":"2015","unstructured":"Bhutani VK, Johnson-Hamerman L (2015) The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Fetal Neonatal Med 20:6\u201313. https:\/\/doi.org\/10.1016\/j.siny.2014.12.008","journal-title":"Semin Fetal Neonatal Med"},{"key":"6421_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/adc.33.171.403","volume":"33","author":"VM Crosse","year":"1958","unstructured":"Crosse VM, Wallis PG, Walsh AM (1958) Replacement transfusion as a means of preventing kernicterus of prematurity. Arch Dis Child 33:403\u2013408. https:\/\/doi.org\/10.1136\/adc.33.171.403","journal-title":"Arch Dis Child"},{"key":"6421_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1542\/peds.21.6.875","volume":"21","author":"RC Harris","year":"1958","unstructured":"Harris RC, Lucey JF, Maclean JR (1958) Kernicterus in premature infants associated with low concentrations of bilirubin in the plasma. Pediatrics 21:875\u2013884","journal-title":"Pediatrics"},{"key":"6421_CR45","unstructured":"Sass-Kortsak A. Kernicterus-Report based on a symposium held at the IX International Congress of Paediatrics, Montreal, July 1959. University of Toronto Press"},{"key":"6421_CR46","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/s0140-6736(58)91849-x","volume":"1","author":"RJ Cremer","year":"1958","unstructured":"Cremer RJ, Perryman PW, Richards DH (1958) Influence of light on the hyperbilirubinaemia of infants. Lancet 1:1094\u20131097. https:\/\/doi.org\/10.1016\/s0140-6736(58)91849-x","journal-title":"Lancet"},{"key":"6421_CR47","first-page":"114","volume":"6","author":"L Johnson","year":"1970","unstructured":"Johnson L, Schutta HS (1970) Quantitative assessment of the effects of light treatment in infant Gunn rats. Birth Defects Orig Artic Ser 6:114\u2013118","journal-title":"Birth Defects Orig Artic Ser"},{"key":"6421_CR48","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/adc.40.214.666","volume":"40","author":"PM Broughton","year":"1965","unstructured":"Broughton PM, Rossiter EJ, Warren CB et al (1965) Effect of blue light on hyperbilirubinaemia. Arch Dis Child 40:666\u2013671. https:\/\/doi.org\/10.1136\/adc.40.214.666","journal-title":"Arch Dis Child"},{"key":"6421_CR49","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/bmj.2.5707.482-b","volume":"1","author":"J Lucey","year":"1970","unstructured":"Lucey J (1970) Blue light and jaundice. Br Med J 1:482\u2013483. https:\/\/doi.org\/10.1136\/bmj.2.5707.482-b","journal-title":"Br Med J"},{"key":"6421_CR50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/adc.51.6.476","volume":"51","author":"F Ebbsen","year":"1976","unstructured":"Ebbsen F, Moller J (1976) Blue double light. Improved method of phototherapy. Arch Dis Child 51:476\u2013478. https:\/\/doi.org\/10.1136\/adc.51.6.476","journal-title":"Arch Dis Child"},{"key":"6421_CR51","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/adc.30.154.501","volume":"30","author":"VM Crosse","year":"1955","unstructured":"Crosse VM, Meyer TC, Gerrard JW (1955) Kernicterus and prematurity. Arch Dis Child 30:501\u2013508. https:\/\/doi.org\/10.1136\/adc.30.154.501","journal-title":"Arch Dis Child"},{"key":"6421_CR52","first-page":"108","volume":"13","author":"AM Freedman","year":"1960","unstructured":"Freedman AM, Braine M, Heimer CB et al (1960) The influence of hyperbilirubinemia on the early development of the premature. Psychiatr Res Rep Am Psychiatr Assoc 13:108\u2013127","journal-title":"Psychiatr Res Rep Am Psychiatr Assoc"},{"key":"6421_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0140-6736(60)92902-0","volume":"1","author":"IH Gosset","year":"1960","unstructured":"Gosset IH (1960) A perspex icterometer for neonates. Lancet 1:87\u201388. https:\/\/doi.org\/10.1016\/s0140-6736(60)92902-0","journal-title":"Lancet"},{"issue":"5","key":"6421_CR54","doi-asserted-by":"publisher","first-page":"F317","DOI":"10.1136\/adc.2008.150714","volume":"94","author":"R Keren","year":"2009","unstructured":"Keren R, Tremont K, Luan X, Cnaan A (2009) Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed 94(5):F317-322. https:\/\/doi.org\/10.1136\/adc.2008.150714","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6421_CR55","first-page":"827","volume":"49","author":"WH Jaeschke","year":"1950","unstructured":"Jaeschke WH (1950) Interpretation of serum bilirubin values obtained with the Ducci and Watson modification of the Malloy and Evelyn method. Wis Med J 49:827","journal-title":"Wis Med J"},{"key":"6421_CR56","first-page":"1004","volume":"43","author":"ZK Shihabi","year":"1977","unstructured":"Shihabi ZK, Scaro J (1977) A modified Malloy-Evelyn procedure for total bilirubin in microsamples. Am J Med Technol 43:1004\u20131007","journal-title":"Am J Med Technol"},{"key":"6421_CR57","first-page":"164","volume":"14","author":"LJ Johnson","year":"1957","unstructured":"Johnson LJ (1957) A micro method for the estimation of serum bilirubin. J Med Lab Technol 14:164\u2013168","journal-title":"J Med Lab Technol"},{"key":"6421_CR58","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/archpedi.1969.02100040456007","volume":"118","author":"LI Kramer","year":"1969","unstructured":"Kramer LI (1969) Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 118:454\u2013458. https:\/\/doi.org\/10.1001\/archpedi.1969.02100040456007","journal-title":"Am J Dis Child"},{"key":"6421_CR59","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/adc.57.9.708","volume":"57","author":"M Sheridan-Pereira","year":"1982","unstructured":"Sheridan-Pereira M, Gorman W (1982) Transcutaneous bilirubinometry: an evaluation. Arch Dis Child 57:708\u2013710. https:\/\/doi.org\/10.1136\/adc.57.9.708","journal-title":"Arch Dis Child"},{"key":"6421_CR60","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/s0022-3476(81)80721-4","volume":"98","author":"T Hegyi","year":"1981","unstructured":"Hegyi T, Hiatt IM, Indyk L (1981) Transcutaneous bilirubinometry. I. Correlations in term infants. J Pediatr 98:454\u2013457. https:\/\/doi.org\/10.1016\/s0022-3476(81)80721-4","journal-title":"Correlations in term infants. J Pediatr"},{"key":"6421_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1542\/peds.65.2.195","volume":"65","author":"I Yamanouchi","year":"1980","unstructured":"Yamanouchi I, Yamauchi Y, Igarashi I (1980) Transcutaneous bilirubinometry: preliminary studies of noninvasive transcutaneous bilirubin meter in the Okayama National Hospital. Pediatrics 65:195\u2013202","journal-title":"Pediatrics"},{"issue":"2","key":"6421_CR62","doi-asserted-by":"publisher","first-page":"e2021053928","DOI":"10.1542\/peds.2021-053928","volume":"150","author":"A Shapiro","year":"2022","unstructured":"Shapiro A, Anderson J, Mtenthaonga P et al (2022) Evaluation of a point-of-care test for bilirubin in Malawi. Pediatrics 150(2):e2021053928. https:\/\/doi.org\/10.1542\/peds.2021-053928","journal-title":"Pediatrics"},{"key":"6421_CR63","doi-asserted-by":"publisher","first-page":"e0183882","DOI":"10.1371\/journal.pone.0183882","volume":"12","author":"BO Olusanya","year":"2017","unstructured":"Olusanya BO, Slusher TM, Imosemi DO, Emokpae AA (2017) Maternal detection of neonatal jaundice during birth hospitalization using a novel two-color icterometer. PLoS One 12:e0183882. https:\/\/doi.org\/10.1371\/journal.pone.0183882","journal-title":"PLoS One"},{"key":"6421_CR64","doi-asserted-by":"publisher","first-page":"e20182039","DOI":"10.1542\/peds.2018-2039","volume":"143","author":"AC Lee","year":"2019","unstructured":"Lee AC, Folger LV, Rahman M et al (2019) A novel icterometer for hyperbilirubinemia screening in low-resource settings. Pediatrics 143:e20182039. https:\/\/doi.org\/10.1542\/peds.2018-2039","journal-title":"Pediatrics"},{"key":"6421_CR65","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/tropej\/fmaa026","volume":"66","author":"B Kamineni","year":"2020","unstructured":"Kamineni B, Tanniru A, Vardhelli V et al (2020) Accuracy of Bilistick (a point-of-care device) to detect neonatal hyperbilirubinemia. J Trop Pediatr 66:630\u2013636. https:\/\/doi.org\/10.1093\/tropej\/fmaa026","journal-title":"J Trop Pediatr"},{"key":"6421_CR66","doi-asserted-by":"publisher","first-page":"e20170312","DOI":"10.1542\/peds.2017-0312","volume":"140","author":"JA Taylor","year":"2017","unstructured":"Taylor JA, Stout JW, de Greef L et al (2017) Use of a smartphone app to assess neonatal jaundice. Pediatrics 140:e20170312. https:\/\/doi.org\/10.1542\/peds.2017-0312","journal-title":"Pediatrics"},{"key":"6421_CR67","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12913-024-11141-6","volume":"24","author":"G Jim\u00e9nez-D\u00edaz","year":"2024","unstructured":"Jim\u00e9nez-D\u00edaz G, Aune A, Elizarrar\u00e1s-Rivas J et al (2024) Neonatal jaundice detection in low-resource Mexican settings: possibilities and barriers for innovation with mobile health. BMC Health Serv Res 24:671. https:\/\/doi.org\/10.1186\/s12913-024-11141-6","journal-title":"BMC Health Serv Res"},{"key":"6421_CR68","doi-asserted-by":"publisher","first-page":"e002242","DOI":"10.1136\/bmjpo-2023-002242","volume":"9","author":"A Aune","year":"2025","unstructured":"Aune A, J\u00edmenez-D\u00edaz G, Gierman LM et al (2025) Smartphone-based screening of neonatal jaundice in three populations in low and middle-income countries: a cross-sectional study. BMJ Paediatr Open 9:e002242. https:\/\/doi.org\/10.1136\/bmjpo-2023-002242","journal-title":"BMJ Paediatr Open"},{"key":"6421_CR69","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/bios14050254","volume":"14","author":"CJ Hazarika","year":"2024","unstructured":"Hazarika CJ, Borah A, Gogoi P et al (2024) Development of non-invasive biosensors for neonatal jaundice detection: a review. Biosensors (Basel) 14:254. https:\/\/doi.org\/10.3390\/bios14050254","journal-title":"Biosensors (Basel)"},{"key":"6421_CR70","doi-asserted-by":"publisher","first-page":"103088","DOI":"10.1016\/j.artmed.2025.103088","volume":"162","author":"FO Salami","year":"2025","unstructured":"Salami FO, Muzammel M, Mourchid Y, Othmani A (2025) Artificial Intelligence non-invasive methods for neonatal jaundice detection: a review. Artif Intell Med 162:103088. https:\/\/doi.org\/10.1016\/j.artmed.2025.103088","journal-title":"Artif Intell Med"},{"key":"6421_CR71","doi-asserted-by":"publisher","first-page":"e2450260","DOI":"10.1001\/jamanetworkopen.2024.50260","volume":"7","author":"AJH Ngeow","year":"2024","unstructured":"Ngeow AJH, Moosa AS, Tan MG et al (2024) Development and validation of a smartphone application for neonatal jaundice screening. JAMA Netw Open 7:e2450260. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.50260","journal-title":"JAMA Netw Open"},{"key":"6421_CR72","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/jpc.16287","volume":"59","author":"AJH Ngeow","year":"2023","unstructured":"Ngeow AJH, Tan MG, Dong X et al (2023) Validation of a smartphone-based screening tool (Biliscan) for neonatal jaundice in a multi-ethnic neonatal population. J Paediatr Child Health 59:288\u2013297. https:\/\/doi.org\/10.1111\/jpc.16287","journal-title":"J Paediatr Child Health"},{"key":"6421_CR73","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1542\/peds.2009-0128","volume":"124","author":"US Preventive Services Task Force","year":"2009","unstructured":"US Preventive Services Task Force (2009) Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: US Preventive Services Task Force recommendation statement. Pediatrics 124:1172\u20131177. https:\/\/doi.org\/10.1542\/peds.2009-0128","journal-title":"Pediatrics"},{"key":"6421_CR74","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1542\/peds.2014-1146","volume":"134","author":"EK Darling","year":"2014","unstructured":"Darling EK, Ramsay T, Sprague AE et al (2014) Universal bilirubin screening and health care utilization. Pediatrics 134:e1017-1024. https:\/\/doi.org\/10.1542\/peds.2014-1146","journal-title":"Pediatrics"},{"key":"6421_CR75","unstructured":"The Canadian Paediatric Society Guidelines for detection and management of hyperbilirubinemia in term and late preterm newborns (\u226535 weeks gestational age). https:\/\/cps.ca\/en\/documents\/position\/hyperbilirubinemia-newborns"},{"key":"6421_CR76","unstructured":"German guidelines for diagnosis of hyperbilirubinemia. https:\/\/gnpi.de\/wp-content\/uploads\/2020\/07\/024-007l_S2k_Hyperbilirubinaemie_Neugeborenen_Diagnostik_Therapie_2015-08.pdf"},{"key":"6421_CR77","doi-asserted-by":"publisher","first-page":"294.e1","DOI":"10.1016\/j.anpedi.2017.03.006","volume":"87","author":"MD S\u00e1nchez-Redondo S\u00e1nchez-Gabriel","year":"2017","unstructured":"S\u00e1nchez-Redondo S\u00e1nchez-Gabriel MD, Leante Castellanos JL, Benavente Fern\u00e1ndez I et al (2017) Guidelines for prevention, detection and management of hyperbilirubinaemia in newborns of 35 or more weeks of gestation. An Pediatr (Barc) 87:294.e1-294.e8. https:\/\/doi.org\/10.1016\/j.anpedi.2017.03.006","journal-title":"An Pediatr (Barc)"},{"key":"6421_CR78","first-page":"685","volume":"48","author":"Editorial Board of Chinese Journal of Pediatrics, Subspecialty Group of Neonatology, The Society of Pediatrics, Chinese Medical Association","year":"2010","unstructured":"Editorial Board of Chinese Journal of Pediatrics, Subspecialty Group of Neonatology, The Society of Pediatrics, Chinese Medical Association (2010) Experts consensus on principles for diagnosis and treatment of neonatal jaundice. Zhonghua Er Ke Za Zhi 48:685\u2013686","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"6421_CR79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/jp.2008.20","volume":"28","author":"M Kaplan","year":"2008","unstructured":"Kaplan M, Merlob P, Regev R (2008) Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 28:389\u2013397. https:\/\/doi.org\/10.1038\/jp.2008.20","journal-title":"J Perinatol"},{"key":"6421_CR80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1824-7288-40-11","volume":"40","author":"C Romagnoli","year":"2014","unstructured":"Romagnoli C, Barone G, Pratesi S et al (2014) Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants \u2265 35 weeks\u2019 gestational age. Ital J Pediatr 40:11. https:\/\/doi.org\/10.1186\/1824-7288-40-11","journal-title":"Ital J Pediatr"},{"key":"6421_CR81","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/archdischild-2016-311556","volume":"102","author":"RC Amos","year":"2017","unstructured":"Amos RC, Jacob H, Leith W (2017) Jaundice in newborn babies under 28 days: NICE guideline 2016 (CG98). Arch Dis Child Educ Pract Ed 102:207\u2013209. https:\/\/doi.org\/10.1136\/archdischild-2016-311556","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"6421_CR82","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.5152\/TurkPediatriArs.2018.01816","volume":"53","author":"A \u00c7oban","year":"2018","unstructured":"\u00c7oban A, T\u00fcrkmen MK, G\u00fcrsoy T (2018) Turkish Neonatal Society guideline to the approach, follow-up, and treatment of neonatal jaundice. Turk Pediatri Ars 53:S172\u2013S179. https:\/\/doi.org\/10.5152\/TurkPediatriArs.2018.01816","journal-title":"Turk Pediatri Ars"},{"key":"6421_CR83","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.4.e53","volume":"109","author":"SU Sarici","year":"2002","unstructured":"Sarici SU, Yurdak\u00f6k M, Serdar MA et al (2002) An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics 109:e53. https:\/\/doi.org\/10.1542\/peds.109.4.e53","journal-title":"Pediatrics"},{"key":"6421_CR84","doi-asserted-by":"publisher","first-page":"e2021054071","DOI":"10.1542\/peds.2021-054071","volume":"149","author":"MF Papacostas","year":"2022","unstructured":"Papacostas MF, Robertson DM, McLean MD et al (2022) Sixth-Hour Trancutaneous Bilirubin and Need for Phototherapy in DAT Positive Newborns. Pediatrics 149:e2021054071. https:\/\/doi.org\/10.1542\/peds.2021-054071","journal-title":"Pediatrics"},{"key":"6421_CR85","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/08880018.2014.887803","volume":"32","author":"H Liu","year":"2015","unstructured":"Liu H, Liu W, Tang X, Wang T (2015) Association between G6PD deficiency and hyperbilirubinemia in neonates: a meta-analysis. Pediatr Hematol Oncol 32:92\u201398. https:\/\/doi.org\/10.3109\/08880018.2014.887803","journal-title":"Pediatr Hematol Oncol"},{"key":"6421_CR86","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/1573396313666170718144025","volume":"13","author":"JF Watchko","year":"2017","unstructured":"Watchko JF (2017) Refractory causes of kernicterus in developed countries: can we eradicate G6PD deficiency triggered and low-bilirubin kernicterus? Curr Pediatr Rev 13:159\u2013168. https:\/\/doi.org\/10.2174\/1573396313666170718144025","journal-title":"Curr Pediatr Rev"},{"key":"6421_CR87","doi-asserted-by":"publisher","first-page":"151360","DOI":"10.1016\/j.semperi.2020.151360","volume":"45","author":"R Vidavalur","year":"2021","unstructured":"Vidavalur R, Ezeaka VC, Bhutani VK (2021) Estimated disease burden and lost economic productivity due to glucose-6-phosphate dehydrogenase deficiency in Nigerian newborns. Semin Perinatol 45:151360. https:\/\/doi.org\/10.1016\/j.semperi.2020.151360","journal-title":"Semin Perinatol"},{"key":"6421_CR88","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41390-024-03611-8","volume":"97","author":"M Kaplan","year":"2025","unstructured":"Kaplan M, Kassirer Y, Hammerman C (2025) Controversies in our understanding of extreme hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatr Res 97:1507\u20131515. https:\/\/doi.org\/10.1038\/s41390-024-03611-8","journal-title":"Pediatr Res"},{"key":"6421_CR89","doi-asserted-by":"publisher","first-page":"e2024068026","DOI":"10.1542\/peds.2024-068026","volume":"154","author":"VK Bhutani","year":"2024","unstructured":"Bhutani VK, Wong RJ, Turkewitz D et al (2024) Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation: technical report. Pediatrics 154:e2024068026. https:\/\/doi.org\/10.1542\/peds.2024-068026","journal-title":"Pediatrics"},{"key":"6421_CR90","doi-asserted-by":"publisher","first-page":"e2022058865","DOI":"10.1542\/peds.2022-058865","volume":"150","author":"JL Slaughter","year":"2022","unstructured":"Slaughter JL, Kemper AR, Newman TB (2022) Technical Report: Diagnosis and management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 150:e2022058865. https:\/\/doi.org\/10.1542\/peds.2022-058865","journal-title":"Pediatrics"},{"key":"6421_CR91","doi-asserted-by":"publisher","first-page":"e001027","DOI":"10.1136\/bmjpo-2021-001027","volume":"5","author":"M Noureldein","year":"2021","unstructured":"Noureldein M, Mupanemunda G, McDermott H et al (2021) Home phototherapy for neonatal jaundice in the UK: a single-centre retrospective service evaluation and parental survey. BMJ Paediatr Open 5:e001027. https:\/\/doi.org\/10.1136\/bmjpo-2021-001027","journal-title":"BMJ Paediatr Open"},{"key":"6421_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03754-8","author":"MC Cnossen","year":"2024","unstructured":"Cnossen MC, Spaan J, Fleischmann MS et al (2024) Home phototherapy for neonatal hyperbilirubinemia: current practices and attitudes. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-024-03754-8","journal-title":"Pediatr Res"},{"key":"6421_CR93","doi-asserted-by":"publisher","first-page":"CD010212","DOI":"10.1002\/14651858.CD010212.pub2","volume":"2014","author":"US Malwade","year":"2014","unstructured":"Malwade US, Jardine LA (2014) Home- versus hospital-based phototherapy for the treatment of non-haemolytic jaundice in infants at more than 37 weeks\u2019 gestation. Cochrane Database Syst Rev 2014:CD010212. https:\/\/doi.org\/10.1002\/14651858.CD010212.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6421_CR94","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00431-021-03932-4","volume":"180","author":"M Pettersson","year":"2021","unstructured":"Pettersson M, Eriksson M, Albinsson E, Ohlin A (2021) Home phototherapy for hyperbilirubinemia in term neonates-an unblinded multicentre randomized controlled trial. Eur J Pediatr 180:1603\u20131610. https:\/\/doi.org\/10.1007\/s00431-021-03932-4","journal-title":"Eur J Pediatr"},{"key":"6421_CR95","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41390-023-02712-0","volume":"94","author":"S Rasiah","year":"2023","unstructured":"Rasiah S, Jegathesan T, Campbell DM et al (2023) Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia. Pediatr Res 94:2092\u20132097. https:\/\/doi.org\/10.1038\/s41390-023-02712-0","journal-title":"Pediatr Res"},{"key":"6421_CR96","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.arcped.2014.02.005","volume":"21","author":"A Cortey","year":"2014","unstructured":"Cortey A, Elzaabi M, Waegemans T et al (2014) Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis. Arch Pediatr 21:976\u2013983. https:\/\/doi.org\/10.1016\/j.arcped.2014.02.005","journal-title":"Arch Pediatr"},{"key":"6421_CR97","doi-asserted-by":"publisher","first-page":"CD003313","DOI":"10.1002\/14651858.CD003313.pub2","volume":"3","author":"C Zwiers","year":"2018","unstructured":"Zwiers C, Scheffer-Rath ME, Lopriore E et al (2018) Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database Syst Rev 3:CD003313. https:\/\/doi.org\/10.1002\/14651858.CD003313.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6421_CR98","doi-asserted-by":"publisher","first-page":"fmac004","DOI":"10.1093\/tropej\/fmac004","volume":"68","author":"RM Ramachandran","year":"2022","unstructured":"Ramachandran RM, Srinivasan R (2022) Clinical profile and outcome following exchange transfusion for neonatal jaundice in a tertiary care centre. J Trop Pediatr 68:fmac004. https:\/\/doi.org\/10.1093\/tropej\/fmac004","journal-title":"J Trop Pediatr"},{"key":"6421_CR99","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0303-7207(89)90199-8","volume":"61","author":"DW Williams","year":"1989","unstructured":"Williams DW, Williams ED, Wynford-Thomas D (1989) Evidence for autocrine production of IGF-1 in human thyroid adenomas. Mol Cell Endocrinol 61:139\u2013143. https:\/\/doi.org\/10.1016\/0303-7207(89)90199-8","journal-title":"Mol Cell Endocrinol"},{"key":"6421_CR100","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3109\/14767058.2014.960832","volume":"28","author":"N Hakan","year":"2015","unstructured":"Hakan N, Zenciroglu A, Aydin M et al (2015) Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey. J Matern Fetal Neonatal Med 28:1537\u20131541. https:\/\/doi.org\/10.3109\/14767058.2014.960832","journal-title":"J Matern Fetal Neonatal Med"},{"key":"6421_CR101","doi-asserted-by":"publisher","first-page":"CD011891","DOI":"10.1002\/14651858.CD011891.pub2","volume":"8","author":"NM Lai","year":"2017","unstructured":"Lai NM, Ahmad Kamar A, Choo YM et al (2017) Fluid supplementation for neonatal unconjugated hyperbilirubinaemia. Cochrane Database Syst Rev 8:CD011891. https:\/\/doi.org\/10.1002\/14651858.CD011891.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6421_CR102","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41372-021-01223-2","volume":"42","author":"WN Rosenfeld","year":"2022","unstructured":"Rosenfeld WN, Hudak ML, Ruiz N et al (2022) Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease. J Perinatol 42:110\u2013115. https:\/\/doi.org\/10.1038\/s41372-021-01223-2","journal-title":"J Perinatol"},{"key":"6421_CR103","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/jp.2016.22","volume":"36","author":"VK Bhutani","year":"2016","unstructured":"Bhutani VK, Poland R, Meloy LD et al (2016) Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. J Perinatol 36:533\u2013539. https:\/\/doi.org\/10.1038\/jp.2016.22","journal-title":"J Perinatol"},{"key":"6421_CR104","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.siny.2009.11.004","volume":"15","author":"DK Stevenson","year":"2010","unstructured":"Stevenson DK, Wong RJ (2010) Metalloporphyrins in the management of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med 15:164\u2013168. https:\/\/doi.org\/10.1016\/j.siny.2009.11.004","journal-title":"Semin Fetal Neonatal Med"},{"key":"6421_CR105","doi-asserted-by":"publisher","first-page":"2549161","DOI":"10.1155\/2022\/2549161","volume":"2022","author":"P Poudel","year":"2022","unstructured":"Poudel P, Adhikari S (2022) Efficacy and safety concerns with Sn-mesoporphyrin as an adjunct therapy in neonatal hyperbilirubinemia: a literature review. Int J Pediatr 2022:2549161. https:\/\/doi.org\/10.1155\/2022\/2549161","journal-title":"Int J Pediatr"},{"key":"6421_CR106","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/children10071192","volume":"10","author":"SK Shabo","year":"2023","unstructured":"Shabo SK, Gargary KH, Erdeve O (2023) Indirect neonatal hyperbilirubinemia and the role of fenofibrate as an adjuvant to phototherapy. Children (Basel) 10:1192. https:\/\/doi.org\/10.3390\/children10071192","journal-title":"Children (Basel)"},{"key":"6421_CR107","doi-asserted-by":"publisher","unstructured":"Wijaya LA, Widiastuti PW, Nesa NNM, Putra IGNS (2025) The effect of probiotics supplementation in neonatal jaundice therapy: a systematic review. J Neonatal Perinatal Med 19345798251350382. https:\/\/doi.org\/10.1177\/19345798251350382","DOI":"10.1177\/19345798251350382"},{"key":"6421_CR108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12937-025-01126-4","volume":"24","author":"M-L Tsai","year":"2025","unstructured":"Tsai M-L, Shen S-P, Chen Y-T et al (2025) Effects of phototherapy combined with Lactobacillus salivarius AP-32 or Bifidobacterium animalis subsp. lactis CP-9 on improving neonatal jaundice and gut microbiome health: a randomized double-blind clinical study. Nutr J 24:73. https:\/\/doi.org\/10.1186\/s12937-025-01126-4","journal-title":"Nutr J"},{"key":"6421_CR109","doi-asserted-by":"publisher","first-page":"e083641","DOI":"10.1136\/bmjopen-2023-083641","volume":"14","author":"BK Alemu","year":"2024","unstructured":"Alemu BK, Lee MW, Leung MBW et al (2024) Preventive effect of prenatal maternal oral probiotic supplementation on neonatal jaundice (POPS Study): A protocol for the randomised double-blind placebo-controlled clinical trial. BMJ Open 14:e083641. https:\/\/doi.org\/10.1136\/bmjopen-2023-083641","journal-title":"BMJ Open"},{"key":"6421_CR110","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41372-024-01941-3","volume":"44","author":"DK Stevenson","year":"2024","unstructured":"Stevenson DK, Wells GS, Wong RJ (2024) Is it time for a precision health approach to the management of newborn hyperbilirubinemia? J Perinatol 44:920\u2013923. https:\/\/doi.org\/10.1038\/s41372-024-01941-3","journal-title":"J Perinatol"},{"key":"6421_CR111","unstructured":"The effect and mechanism of gene variation on neonatal hyperbilirubinemia. https:\/\/www.clinicaltrials.gov\/study\/NCT06186349?term=AREA%5BConditionSearch%5D(%22Hyperbilirubinemia%22)%20AND%20AREA%5BBasicSearch%5D(gene%20therapy)&rank=1"},{"key":"6421_CR112","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.1038\/s41467-024-51947-w","volume":"15","author":"P Sol\u00e9-Navais","year":"2024","unstructured":"Sol\u00e9-Navais P, Juodakis J, Ytterberg K et al (2024) Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolism. Nat Commun 15:7550. https:\/\/doi.org\/10.1038\/s41467-024-51947-w","journal-title":"Nat Commun"},{"key":"6421_CR113","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1159\/000535970","volume":"121","author":"D Morimoto","year":"2024","unstructured":"Morimoto D, Washio Y, Fukuda K et al (2024) Machine learning to improve accuracy of transcutaneous bilirubinometry. Neonatology 121:772\u2013779. https:\/\/doi.org\/10.1159\/000535970","journal-title":"Neonatology"},{"key":"6421_CR114","doi-asserted-by":"publisher","first-page":"105538","DOI":"10.1016\/j.earlhumdev.2022.105538","volume":"165","author":"J Guedalia","year":"2022","unstructured":"Guedalia J, Farkash R, Wasserteil N et al (2022) Primary risk stratification for neonatal jaundice among term neonates using machine learning algorithm. Early Hum Dev 165:105538. https:\/\/doi.org\/10.1016\/j.earlhumdev.2022.105538","journal-title":"Early Hum Dev"},{"key":"6421_CR115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41390-019-0384-x","volume":"86","author":"I Daunhawer","year":"2019","unstructured":"Daunhawer I, Kasser S, Koch G et al (2019) Enhanced early prediction of clinically relevant neonatal hyperbilirubinemia with machine learning. Pediatr Res 86:122\u2013127. https:\/\/doi.org\/10.1038\/s41390-019-0384-x","journal-title":"Pediatr Res"},{"key":"6421_CR116","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41372-023-01862-7","volume":"44","author":"VK Bhutani","year":"2024","unstructured":"Bhutani VK, Vidavalur R, Wong RJ (2024) Advances to diminish global newborn kernicterus mortality. J Perinatol 44:493\u2013500. https:\/\/doi.org\/10.1038\/s41372-023-01862-7","journal-title":"J Perinatol"},{"key":"6421_CR117","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.earlhumdev.2017.09.008","volume":"114","author":"TM Slusher","year":"2017","unstructured":"Slusher TM, Day LT, Ogundele T et al (2017) Filtered sunlight, solar powered phototherapy and other strategies for managing neonatal jaundice in low-resource settings. Early Hum Dev 114:11\u201315. https:\/\/doi.org\/10.1016\/j.earlhumdev.2017.09.008","journal-title":"Early Hum Dev"},{"key":"6421_CR118","doi-asserted-by":"publisher","first-page":"eabe3793","DOI":"10.1126\/sciadv.abe3793","volume":"7","author":"G Inamori","year":"2021","unstructured":"Inamori G, Kamoto U, Nakamura F et al (2021) Neonatal wearable device for colorimetry-based real-time detection of jaundice with simultaneous sensing of vitals. Sci Adv 7:eabe3793. https:\/\/doi.org\/10.1126\/sciadv.abe3793","journal-title":"Sci Adv"},{"key":"6421_CR119","doi-asserted-by":"publisher","first-page":"28012","DOI":"10.1021\/acsnano.4c06191","volume":"18","author":"RS Tabatabaee","year":"2024","unstructured":"Tabatabaee RS, Naghdi T, Peyravian M et al (2024) An invisible dermal nanotattoo-based smart wearable sensor for eDiagnostics of jaundice. ACS Nano 18:28012\u201328025. https:\/\/doi.org\/10.1021\/acsnano.4c06191","journal-title":"ACS Nano"},{"key":"6421_CR120","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2023.12.030","volume":"153","author":"N Vallamkonda","year":"2024","unstructured":"Vallamkonda N, Bandyopadhyay T, Maria A (2024) A study of general movement assessment and its association with neurodevelopmental outcome at age 12 to 15 months among term neonates with hyperbilirubinemia. Pediatr Neurol 153:77\u201383. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.12.030","journal-title":"Pediatr Neurol"},{"key":"6421_CR121","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/jpc.16489","volume":"59","author":"AJ McGillivray","year":"2023","unstructured":"McGillivray AJ, Polverino J, Badawi N, Evans NJ (2023) Prospective cohort study of neurodevelopmental outcomes following extreme neonatal hyperbilirubinaemia in Australia. J Paediatr Child Health 59:1244\u20131250. https:\/\/doi.org\/10.1111\/jpc.16489","journal-title":"J Paediatr Child Health"},{"key":"6421_CR122","doi-asserted-by":"publisher","first-page":"fmae020","DOI":"10.1093\/tropej\/fmae020","volume":"70","author":"C Coraizin","year":"2024","unstructured":"Coraizin C, Vreede H, Van Niekerk C, Joolay Y (2024) Incidence, aetiology and short term outcomes of extreme hyperbilirubinaemia, in term infants born in the Western health subdistrict of Cape Town, South Africa between 2019 and 2020. J Trop Pediatr 70:fmae020. https:\/\/doi.org\/10.1093\/tropej\/fmae020","journal-title":"J Trop Pediatr"},{"key":"6421_CR123","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/jp.2008.199","volume":"29","author":"CE Ahlfors","year":"2009","unstructured":"Ahlfors CE, Amin SB, Parker AE (2009) Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol 29:305\u2013309. https:\/\/doi.org\/10.1038\/jp.2008.199","journal-title":"J Perinatol"},{"key":"6421_CR124","doi-asserted-by":"publisher","first-page":"113880","DOI":"10.1016\/j.jpeds.2023.113880","volume":"266","author":"SB Amin","year":"2024","unstructured":"Amin SB, Saluja S, Kler N (2024) Unbound bilirubin and acute bilirubin encephalopathy in infants born late preterm and term with significant hyperbilirubinemia. J Pediatr 266:113880. https:\/\/doi.org\/10.1016\/j.jpeds.2023.113880","journal-title":"J Pediatr"},{"key":"6421_CR125","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000505818","volume":"117","author":"TM Bahr","year":"2020","unstructured":"Bahr TM, Shakib JH, Stipelman CH et al (2020) Improving the bilirubin management program in the newborn nursery: background, aims, and protocol. Neonatology 117:358\u2013364. https:\/\/doi.org\/10.1159\/000505818","journal-title":"Neonatology"},{"key":"6421_CR126","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/jpc.15925","volume":"58","author":"M Khajehei","year":"2022","unstructured":"Khajehei M, Gidaszewski B, Maheshwari R, McGee TM (2022) Clinical outcomes and cost-effectiveness of large-scale midwifery-led, paediatrician-overseen home phototherapy and neonatal jaundice surveillance: a retrospective cohort study. J Paediatr Child Health 58:1159\u20131167. https:\/\/doi.org\/10.1111\/jpc.15925","journal-title":"J Paediatr Child Health"},{"key":"6421_CR127","doi-asserted-by":"publisher","unstructured":"Spaan J, Been JV, Wall\u00e9 Y et al (2025) First in-human pilot study of wearable phototherapy for neonatal hyperbilirubinaemia. Eur J Pediatr 184(7):407. https:\/\/doi.org\/10.1007\/s00431-025-06239-w","DOI":"10.1007\/s00431-025-06239-w"},{"key":"6421_CR128","doi-asserted-by":"publisher","unstructured":"Ebbesen F, Madsen PH, Rodrigo-Domingo M, Donneborg ML (2025) Bilirubin isomers during LED phototherapy of hyperbilirubinemic neonates, blue-green (~478\u2009nm) vs blue. Pediatr Res 97(5):1623\u20131628. https:\/\/doi.org\/10.1038\/s41390-024-03493-w","DOI":"10.1038\/s41390-024-03493-w"},{"key":"6421_CR129","doi-asserted-by":"publisher","unstructured":"Zarkesh M, Mahdipour S, Aghili S et al (2023) Evaluation of therapeutic effect of oral Ursodeoxycholic Acid on indirect hyperbilirubinemia in term neonates undergoing phototherapy: A randomized controlled clinical trial. PLoS One 18(12):e0273516. https:\/\/doi.org\/10.1371\/journal.pone.0273516","DOI":"10.1371\/journal.pone.0273516"},{"key":"6421_CR130","doi-asserted-by":"publisher","unstructured":"Nasief H, Alaifan MA, Tamur S et al (2024) Effectiveness of phototherapy with and without probiotics for the treatment of indirect hyperbilirubinaemia in preterm neonates: a randomised controlled trial. Paediatr Int Child Health 44(1):24\u201329. https:\/\/doi.org\/10.1080\/20469047.2024.2328416","DOI":"10.1080\/20469047.2024.2328416"},{"key":"6421_CR131","doi-asserted-by":"publisher","unstructured":"Eghbalian F, Sabzehei MK, Talesh ST, Raeisi R, Jenabi E (2024) The effect of probiotics on phototherapy for bilirubin reduction in term neonates: a randomized controlled trial. Curr Pediatr Rev 21(1):85\u201390. https:\/\/doi.org\/10.2174\/0115733963257942231024100105","DOI":"10.2174\/0115733963257942231024100105"},{"key":"6421_CR132","doi-asserted-by":"publisher","unstructured":"Deshmukh J, Deshmukh M, Patole S (2019) Probiotics for the management of neonatal hyperbilirubinemia: a systematic review of randomized controlled trials. J Matern Fetal Neonatal Med 32(1):154\u2013163. https:\/\/doi.org\/10.1080\/14767058.2017.1369520","DOI":"10.1080\/14767058.2017.1369520"},{"key":"6421_CR133","doi-asserted-by":"publisher","unstructured":"Nikouei M, Cheraghi M, Mansouri M, Hemmatpour S, Moradi Y (2024) The effect of oral zinc sulfate supplementation on hospitalized infants with hyperbilirubinemia: a double-blind randomized clinical trial. Eur J Pediatr 183(11):4649\u20134658. https:\/\/doi.org\/10.1007\/s00431-024-05739-5","DOI":"10.1007\/s00431-024-05739-5"},{"key":"6421_CR134","doi-asserted-by":"publisher","unstructured":"Sharma D, Farahbakhsh N, Sharma P, Shastri S (2017) Role of oral zinc supplementation for reduction of neonatal hyperbilirubinemia: a systematic review of current evidence. J Matern Fetal Neonatal Med 30(16):1953\u20131962. https:\/\/doi.org\/10.1080\/14767058.2016.1234600","DOI":"10.1080\/14767058.2016.1234600"},{"key":"6421_CR135","doi-asserted-by":"publisher","unstructured":"Yang L, Wu D, Wang B, Bu X, Tang J (2018) The influence of zinc sulfate on neonatal jaundice: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 31(10):1311\u20131317. https:\/\/doi.org\/10.1080\/14767058.2017.1315659","DOI":"10.1080\/14767058.2017.1315659"},{"key":"6421_CR136","doi-asserted-by":"publisher","unstructured":"Inamori G, Kamoto U, Nakamura F et al (2021) Neonatal wearable device for colorimetry-based real-time detection of jaundice with simultaneous sensing of vitals. Sci Adv 7(10):eabe3793. https:\/\/doi.org\/10.1126\/sciadv.abe3793","DOI":"10.1126\/sciadv.abe3793"},{"key":"6421_CR137","unstructured":"Gene Therapy for Crigler Najjar Syndrome Type I. NCT06641154. https:\/\/clinicaltrials.gov\/study\/NCT06641154?cond=Crigler%20Najjar%20Syndrome%20Type%20I&viewType=Table&rank=1"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06421-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T03:27:09Z","timestamp":1760326029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06421-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":137,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6421"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06421-0","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"653"}}